IP Library Granted Patent US 11,053,188
Granted Patent B2
US 11,053,188 · App. 16/764,666 · Granted Jul 6, 2021

Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides

Inventors: Raphael Dumeunier (Stein, CH); Tomas Smejkal (Stein, CH); Brijnandan Premnath Mishra (Ilhas Goa, IN); Vijayagopal Raman Gopalsamuthiram (Ilhas Goa, IN); Edouard Godineau (Stein, CH); Anthony Cornelius O'Sullivan (Stein, CH)
Assignee: SYNGENTA PARTICIPATIONS AG
C07C231/065B01J21/02C07C45/44C07C45/54C07C47/457C07C49/39C07C49/467C07C49/593C07C49/647C07C49/697C07C209/26C07C211/40C07C231/02C07C231/06C07D213/803C07B2200/07C07C233/58C07C2601/02C07C2601/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,053,188
App. No.
16/764,666
Granted
Jul 6, 2021
Kind
B2
Abstract

The present invention relates to a process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides by reacting (a) cyclopropylcarbonitrile to a cyclopropylcarbaldehyde, (b) further reacting to a cyclobutanone, or (d′) further reacting to an enamide, (c) further reacting to enantiomerically and diastereomerically enriched cyclobutane amines, or (d) further reacting to an enamide and (e) to an enantiomerically and diastereomerically enriched cyclobutylamide to obtain (f) an enantiomerically and diastereomerically enriched cyclobutane amine, and (g) further reacting to an enantiomerically and diastereomerically enriched cyclobutane amide.

Claims (70)

1. A process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amides comprising

(a) reducing the nitrile moiety of a compound of formula (I) to an aldehyde

wherein A is selected from aryl, heteroaryl, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl, which aryl, heteroaryl, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl are unsubstituted or substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkylsulfanyl, C 1 -C 6 -haloalkylsulfanyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -haloalkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylsulfonyl, C 2 -C 6 -haloalkenyl and C 2 -C 6 -haloalkynyl;

wherein the reduction of the nitrile moiety of the compound of formula (I) is carried out via partial hydrogenation to the corresponding intermediate imine applying H 2 and a metal hydrogenation catalyst, followed by subsequent hydrolysis to the compound of formula (II)

then

(b) reacting the compound of formula (II) in the presence of a suitable Lewis acid to obtain a compound of formula (III)

wherein * indicates a stereocentre, then

(c) reacting a compound of formula (III) with an ammonium salt and H 2 in presence of a chiral transition metal catalyst to obtain an enantiomerically and diastereomerically enriched amine of formula (IV)

wherein * indicates a stereocentre, and then

further reacting the amine of formula (IV) with a compound of formula (X)

wherein Y is a suitable leaving group selected from OH, OR or halogen, R is C 1 -C 6 -alkyl, and E is selected from aryl, heteroaryl, hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl which aryl, heteroaryl, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl are unsubstituted or substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkylsulfanyl, C 1 -C 6 -haloalkylsulfanyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -haloalkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylsulfonyl, C 2 -C 6 -haloalkenyl and C 2 -C 6 -haloalkynyl;

so as to form the enantiomerically and diastereomerically enriched amide of formula (VII)

2. The process according to claim 1 , wherein

A and E are selected from aryl and heteroaryl, which aryl and heteroaryl are unsubstituted or substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy and C 1 -C 6 -haloalkoxy.

3. The process according to claim 1 , wherein

A is phenyl and E is heteroaryl, which phenyl and heteroaryl are unsubstituted or substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy and C 1 -C 6 -haloalkoxy.

4. The process according to claim 1 , wherein the compound of formula (II) is reacted in step (b) in the presence of a Lewis acid selected from AlCl 3 and GaCl 3 .

5. The process according to claim 4 , wherein

1.0-1.5 mole equivalents of AlCl 3 or GaCl 3 relative to the compound of formula (II) are added in step (b).

6. The process according to claim 1 , wherein the chiral transition metal catalyst in step (c) comprises a transition metal selected from Ru, Rh, Ir and Pd, and a chiral ligand with a bidentate phosphor of the general formula (VIII)

wherein Z is a linking group and R 1 , R 2 , R 3 and R 4 are independently selected from aryl, heteroaryl, C1-C6-alkyl and C 3 -C 6 -cycloalkyl, each of which is unsubstituted or substituted with one or more substituents independently selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkyl and halogen.

7. The process according to claim 6 , wherein

the linking group Z is selected from (R and S)-1,1′-binaphthyl, (R and S)-4,4′-bi-1, 3-benzodioxole, (R and S)-2, 2′, 6,6′-tetramethoxy-3, 3′-bipyridine, (R and S)-6,6′-dimethoxy-1, 1′-biphenyl, (R and S)-4,4′, 6,6′ tetramethoxy-1, 1′-biphenyl, 2, 2′-bis-[(R)-cx-(dimethylamino)benzyl]ferrocene, ferrocenyl methyl, ferrocene, benzene and ethyl.

8. The process according to claim 6 , wherein the chiral ligand is selected from

(R)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl,

(R)-2,2′-bis(di-p-tolylphosphino)-1,1′-binaphthyl,

(R)-2,2′-bis[di(3,5-xylyl)phosphino]-1,1′-binaphthyl,

(R)-5,5′-bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole,

(R)-5,5′-bis(di[3,5-xylyl]phosphino)-4,4′-bi-1,3-benzodioxole,

(R)-5,5′-bis[di(3,5-di-tert-butyl-4-methoxyphenyl)phosphino]-4,4′-bi-1,3-benzodioxole,

(S)-1,13-bis(diphenylphosphino)-7,8-dihydro-6H-dibenzo[f,h][1,5]dioxin,

(R)-2,2′,6,6′-tetramethoxy-4,4′-bis(di(3,5-xylyl)phosphino)-3,3′-bipyridine,

(R)-2,2′-bis(diphenylphosphino)-6,6′-dimethoxy-1,1′-biphenyl,

(R)-2,2′-bis(diphenylphosphino)-4,4′,6,6′-tetramethoxy-1,1′-biphenyl,

(R)-6,6′-bis(diphenylphosphino)-2,2′,3,3′-tetrahydro-5,5′-bi-1,4-benzodioxin,

(R)-(+)-2,2′-bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl,

(R)-(+)-2,2′-bis(di-3,5-xylylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl,

(R)-5,5′-bis(diphenylphosphino)-2,2,2′,2′-tetrafluoro-4,4′-bi-1,3-benzodioxole,

(S)-1-[(S)-1-[di(3,5-xylyl)phosphino]ethyl]-2-[2-[di(3,5-xylyl)phosphino]phenyl]ferrocene, and

(S)-1-[(S)-1-[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]ethyl]-2-[2-(diphenylphosphino)phenyl]ferrocene.

9. The process according to claim 6 , wherein

the chiral transition metal catalyst is selected from [RuCl(p-cymene)((S)-DM-SEGPHOS)]Cl, [RuCl(p-cymene)((R)-DM-SEGPHOS)]Cl, [NH 2 Me 2 ][(RuCl((R)-xylbinap)) 2 (u-Cl) 3 ], [NH 2 Me 2 ][(RuCl((S)-xylbinap)) 2 (u-Cl) 3 ], Ru(OAc) 2 [(R)-binap], Ru(OAc) 2 [(S)-binap], Ru(OAc) 2 [(R)-xylbinap], Ru(OAc) 2 [(S)-xylbinap], RuCl 2 [(R)-xylbinap][(R)-daipen], RuCl 2 [(S)-xylbinap][(S)-daipen], RuCl 2 [(R)-xylbinap][(R,R)-dpen] and RuCl 2 [(S)-xylbinap][(S,S)-dpen].

10. A process for the preparation of a compound of formula (III)

wherein A is as defined in claim 1 and * indicates a stereocentre, comprising reacting a compound of formula (II)

with a suitable Lewis acid.

11. A process for the preparation of a compound of formula (III)

wherein A is as defined in claim 1 and * indicates a stereocentre, comprising reacting a compound of formula (II)

with a Lewis acid selected from AlCl 3 and GaCl 3 .

12. The process according to claim 11 , wherein 1.0-1.5 mole equivalents of AlCl 3 or GaCl 3 relative to the compound of formula (II) is added.

13. The process according to claim 10 , wherein the compound of formula (III)

wherein A is selected from aryl, heteroaryl, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl, which aryl, heteroaryl, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl are unsubstituted or substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkylsulfanyl, C 1 -C 6 -haloalkylsulfanyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -haloalkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylsulfonyl, C 2 -C 6 -haloalkenyl and C 2 -C 6 -haloalkynyl and * indicates a stereocentre,

is further reacted with an ammonium salt and H 2 in presence of a chiral transition metal catalyst to obtain an enantiomerically and diastereomerically enriched amine of formula (IV)

wherein * indicates a stereocentre, and then

further reacting the amine of formula (IV) with a compound of formula (X)

wherein Y is a suitable leaving group selected from OH, OR or halogen, R is C 1 -C 6 -alkyl, and E is selected from aryl, heteroaryl, hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl which aryl, heteroaryl, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl and C 3 -C 7 -cycloalkyl are unsubstituted or substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkylsulfanyl, C 1 -C 6 -haloalkylsulfanyl, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -haloalkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylsulfonyl, C 2 -C 6 -haloalkenyl and C 2 -C 6 -haloalkynyl;

so as to form the enantiomerically and diastereomerically enriched amide of formula (VII)

14. The process according to claim 13 , wherein the chiral transition metal catalyst comprises a transition metal selected from Ru, Rh, Ir and Pd, and a chiral ligand with a bidentate phosphor of the general formula (VIII)

wherein Z is a linking group and R 1 , R 2 , R 3 and R 4 are independently selected from aryl, heteroaryl, C 1 -C 6 -alkyl and C 3 -C 6 -cycloalkyl, each of which is unsubstituted or substituted with one or more substituents independently selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkyl and halogen.

15. A process for the preparation of a compound of formula (V)

wherein A is as defined in claim 1 , which comprises reacting a compound of formula (II)

in the presence of a Lewis acid selected from AlCl 3 and GaCl 3 to obtain a compound of formula (III)

and further reacting the compound of formula (III) with acetonitrile and a suitable additive, wherein the additive is selected from acyl chlorides, anhydrides or esters.

16. The process according to claim 1 , wherein Y is chloro.

17. The process according to claim 4 , wherein the Lewis acid is AlCl 3 .

18. The process according to claim 6 , wherein the transition metal is Ru.

19. The process according to claim 7 , wherein the linking group Z is (R and S)-1,1′-binaphthyl.

20. The process according to claim 11 , wherein the Lewis acid is AlCl 3 .

21. The process according to claim 13 , wherein Y is chloro.

22. The process according to claim 15 , wherein the Lewis acid is AlCl 3 .

23. The process according to claim 15 , wherein the additive is selected from acetyl chloride, isopropenyl acetate, 4-methoxybenzoyl chloride and p-anisic anhydride.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Feb 28, 2025
From: SYNGENTA PARTICIPATIONS AG; SYNGENTA PARTICIPATIONS AG
To: SYNGENTA CROP PROTECTION AG
Reel/Frame 070362/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2020
From: DUMEUNIER, RAPHAEL; SMEJKAL, TOMAS; MISHRA, BRIJNANDAN PREMNATH; GOPALSAMUTHIRAM, VIJAYAGOPAL RAMAN; GODINEAU, EDOUARD; O'SULLIVAN, ANTHONY CORNELIUS
To: SYNGENTA PARTICIPATIONS AG
Reel/Frame 052972/0810 →